Fingerprint
Dive into the research topics of 'The Benefit-to-Risk Balance of Combining Infliximab With Azathioprine Varies With Age: A Markov Model'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The Benefit-to-Risk Balance of Combining Infliximab With Azathioprine Varies With Age: A Markov Model
Frank I. Scott, Ravy K. Vajravelu, Meenakshi Bewtra, Ronac Mamtani, Dale Lee, David S. Goldberg, James D. Lewis
Research output: Contribution to journal › Article › peer-review
30
Scopus
citations